Stem cell startup Magenta launches with $48.5m
Atlas and Third Rock Ventures have co-led a $48.5 million Series A for Magenta, a Boston start-up hoping to revive the stem cell field with its novel transplant platform.
Magenta
Atlas and Third Rock Ventures have co-led a $48.5 million Series A for Magenta, a Boston start-up hoping to revive the stem cell field with its novel transplant platform.